Frank Bohnenstengel has a significant background in the pharmaceutical industry, with experience in medical affairs, scientific operations, medical science liaison, medical education, and medical information. Frank has held various leadership roles at companies such as Novartis, ViroPharma GmbH, and Bayer, specializing in a range of therapeutic areas including rare diseases, cardiovascular, renal, metabolism, hereditary angioedema, and infectious diseases. Frank's educational background includes a PhD in Pharmacy, Pharmacology, and Chemistry from The Julius Maximilians University of Würzburg, along with research stays in Vietnam and Indonesia.
April, 2021 - present